| Transdermal dopaminergic stimulation with rotigotine in Parkinsonian akinetic crisis. | |
| | |
MedLine Citation:
|
PMID: 19056273 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Akinetic crisis (AC) is a much-feared complication of Parkinson's disease (PD) which may appear upon abrupt cessation or malabsorption of dopaminergic medication due to gastrointestinal tract disorders or acute surgery. Intravenous infusion of amantadine sulphate or subcutaneous administration of apomorphine are established treatment strategies for AC. We speculate whether the use of a non-invasive transdermal application form (patch) of a dopaminergic drug (rotigotine) may represent a useful alternative treatment option. We describe the successful treatment of severe AC using rotigotine in a PD patient with gastro-oesophageal ulcers which precluded administration of any oral medication. This case demonstrates that a rotigotine patch might be effective in the treatment of AC. We suggest that rotigotine may represent a useful treatment option due to its favourable receptor profile and unique application form. In particular, it may be helpful in situations that might provoke AC, such as acute surgery. However, experience of the use of the rotigotine patch in this clinical setting is rather sparse and the patch is currently not approved for this indication. |
| | |
Authors:
|
Manuel Dafotakis; Roland Sparing; Agnes Juzek; Frank Block; Christoph M Kosinski |
Related Documents
:
|
8862073 - Safety and long-term efficacy of revisional surgery in severe obesity. 12743783 - Secondary hemocholecyst after radiofrequency ablation therapy for hepatocellular carcin... 8862073 - Safety and long-term efficacy of revisional surgery in severe obesity. |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2008-12-03 |
Journal Detail:
|
Title: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia Volume: 16 ISSN: 0967-5868 ISO Abbreviation: J Clin Neurosci Publication Date: 2009 Feb |
Date Detail:
|
Created Date: 2009-01-12 Completed Date: 2009-03-26 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9433352 Medline TA: J Clin Neurosci Country: Scotland |
Other Details:
|
Languages: eng Pagination: 335-7 Citation Subset: IM |
Affiliation:
|
Institute of Neuroscience and Biophysics - Medicine, Research Centre Jülich, Leo-Brandt-Str. 1, D-52428 Jülich, Germany. m.dafotakis@fz-juelich.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Cutaneous Dopamine Agonists / administration & dosage* Fear* Humans Malabsorption Syndromes / drug therapy*, etiology Male Middle Aged Parkinsonian Disorders / complications, psychology Severity of Illness Index Tetrahydronaphthalenes / administration & dosage* Thiophenes / administration & dosage* |
| Chemical | |
Reg. No./Substance:
|
0/Dopamine Agonists; 0/Tetrahydronaphthalenes; 0/Thiophenes; 92206-54-7/N 0437 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Variability in spatiotemporal step characteristics and its relationship to walking performance post-...
Next Document: Bilateral mandibular metastases in medulloblastoma.